Marylyn Addo, Zentrum für Innere Medizin, Hamburg: Sex differences in immunity and vaccination

Florian Krammer, Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York: Development of broadly protective influenza virus vaccines

Maria Rosenthal, Department of Virology; Bernhard Nocht Institute for Tropical Medicine, Hamburg: Bunyavirus genome replication and transcription – a structural perspective

Anne Halenius, Institute of Virology; University hospital Freiburg: Cytomegalovirus US11 and MHC-A, engaged in a coevolutionary arms race in hominids

Marco Binder, Research Group: Dynamics of early viral infection and the innate antiviral response; German Cancer Research Center; Heidelberg: Preparing the battle field – how cells remain vigilant against viral intruders

Konstantin Sparrer, Institute of molecular virology, university hospital Ulm:The journey from pandemic to endemic so far – Functional impact of adaptations in non-Spike genes of SARS-CoV-2

Sprecher:

Thomas Krey, Institute of Biochemistry, University of Lübeck: A new class of potent neutralizing human monoclonal antibodies targeting the Hepatitis E virus ORF2 protein

Volker Kinast, Medizinische Mikrobiologie und Virologie, Carl von Ossietzky Universität Oldenburg: Pro- and antiviral host factors of hepatitis E virus entry

Sprecher*innen:

Gülsah Gabriel, Leibniz-Institut für Virologie (LIV), Hamburg: Sex differences in SARS-CoV-2 pathogenesis

Linda Brunotte, Westfälische Wilhelms-Universität, Münster: The ubiquitination landscape of the influenza A virus polymerase

Sprecher*innen:

Denisa Bojkova, Institut für Medizinische Virologie, Universitätsklinikum Frankfurt: Monkeypox: Past, present and future

Sprecher*innen:

William Palmer, Division of Biomedical Informatics and Personalized Medicine, University of Colorado, Aurora, USA: Human herpesvirus diversity is altered in HLA class I binding peptides

Adalbert Krawczyk, Clinic for Infectiology, Medical Research Center, University Hospital Essen, Herbal medicines and UV-radiation to combat SARS-CoV-2.

Sprecher*innen:

Isabella Eckerle, Geneva Centre for Emerging Viral Diseases, Hôpitaux Universitaires de Genève, Université Geneva: Chasing the next SARS-CoV-2 variant and preparing for disease X.

Sprecher*innen:
Kim Hasenkrug, Laboratory of Persistent Viral Diseases, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, Hamilton (USA): Investigation of the role of T cells in SARS-CoV-2 infection of non-human primates.
Wiebke Moskorz, Institut für Virologie, Düsseldorf: NK cell immune modulation by SARS-CoV-2.

Sprecher*innen:
Markus Hoffmann, Deutsches Primatenzentrum, Leibniz-Institut für Primatenforschung, Göttingen: Mutations in the spike protein of emerging SARS-CoV-2 variants affect cell tropism and neutralization sensitivity
Stephanie Pfänder, Abteilung für Molekulare und Medizinische Virologie, Bochum: Interfering with coronavirus infection – the role of type I IFN signaling for coronavirus immune control

Sprecher*innen:
Jez Marston, Division of Infectious Diseases, New York: SARS-CoV-2 infection mediates differential expression of human endogenous retroviruses and long interspersed nuclear elements.
Sebastian Voigt, Institute for Virology, Essen: T cell responses in SARS-CoV-2 infections.

Sprecher*innen:
Ludger Woessmann, ifo Zentrums für Bildungsökonomik, Ludwig-Maximilians-Universität München: The Legacy of Covid-19 in Education.
Felix Dewald, Institut für Virologie, Universität zu Köln: Lolli-Method to screen for SARS-CoV-2 Infection in Children.

Sprecher*innen:
Nico Dragano, Institut für medizinische Soziologie, Universitätsklinikum Düsseldorf: Social determinants of COVID-19 (prevention, infection, disease severity): theory and empirical findings.

Sprecher*innen:
Andreas Held, Fachgebiet Umweltchemie und Luftreinhaltung der TU Berlin: Aerosolprozesse und ihre Rolle bei der Übertragung von SARS-CoV-2.
Stephanie Pfänder, Abteilung für Molekulare und Medzinische Virologie, Universität Bochum: Stability and Inactivation of Corona viruses.

Sprecher*innen:
Andreas Bergthaler, Research Center for Molecular Medicine of the Austrian Academy of Sciences Wien: SARS-CoV-2 evolution and immune evasion.
Ulf Dittmer, Institut für Virologie, Universität Duisburg-Essen: T cell responses in acute and recovered COVID-19 patients.